SUMMARY OF SYMPOSIUM ON FORMULATION FACTORS AFFECTING THERAPEUTIC PERFORMANCE OF DRUG PRODUCTS

被引：0

|

作者：

不详

机构：

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1969年 / 3卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：287 / &

相关论文

共 50 条

[21] Summary of a symposium on natriuretic and digitalis-like factors
Buckalew, VM
Gonick, HC
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1998, 20 (5-6) : 481 - 488
[22] VIRULENCE FACTORS OF ANAEROBIC-BACTERIA - SUMMARY OF THE SYMPOSIUM
BARTLETT, JG
ONDERDONK, AB
REVIEWS OF INFECTIOUS DISEASES, 1979, 1 (02): : 398 - 400
[23] A review of factors affecting therapeutic compliance
Jin, J.
Li, S. C.
VALUE IN HEALTH, 2006, 9 (06) : A272 - A273
[24] THE FACTORS WITCH AFFECTING PRODUCTS FUNCTIONALITY
Sopoian, Cristina Gabriela
Blebea, Ioan
ACTA TECHNICA NAPOCENSIS SERIES-APPLIED MATHEMATICS MECHANICS AND ENGINEERING, 2014, 57 (01): : 109 - 116
[25] SYMPOSIUM ON THERAPEUTIC DRUG-MONITORING IN PSYCHIATRY
MORSELLI, PL
DAHL, S
THERAPEUTIC DRUG MONITORING, 1982, 4 (01) : 15 - 15
[26] Process and formulation variables affecting the performance of a rupturable capsule-based drug delivery system with pulsatile drug release
Dashevsky, A
Bussemer, T
Mohamad, A
Bodmeier, R
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2004, 30 (02) : 171 - 179
[27] SUMMARY OF THE 3RD INTERNATIONAL-SYMPOSIUM ON THERAPEUTIC APHERESIS
不详
ARTIFICIAL ORGANS, 1984, 8 (03) : 273 - 274
[28] HAZARD OF THERAPEUTIC NONEQUIVALENCY OF DRUG PRODUCTS
SCHNELLER, GH
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1969, NS 9 (09): : 455 - +
[29] Therapeutic drug monitoring of individual teicoplanin components; factors affecting pharmacokinetics of individual teicoplanin components
Suzuki, Y.
Itoh, H.
Kawasaki, K.
Sato, Y.
Takeyama, M.
THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 513 - 513
[30] FORMULATION FACTORS INFLUENCING BIOEQUIVALENCE OF DRUG
SJOGREN, J
ACTA PHARMACEUTICA SUECICA, 1978, 15 (04): : 297 - 298

← 1 2 3 4 5 →